 <h1>Tecentriq Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>atezolizumab</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about atezolizumab. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Tecentriq.</p><h2>In Summary</h2><p><b>Common side effects of Tecentriq include:</b> herpes simplex encephalitis, infection, mycobacterium infection, retroperitoneal hemorrhage, sepsis, severe infection, urinary tract infection, colitis, diarrhea, and increased thyroid stimulating hormone level.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to atezolizumab: intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, atezolizumab (the active ingredient contained in Tecentriq) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking atezolizumab:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bladder pain</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>body aches or pain</li>
<li>chills</li>
<li>constipation</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty in breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>general feeling of tiredness and weakness</li>
<li>headache</li>
<li>hoarseness</li>
<li>loss of appetite</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>muscle aches</li>
<li>nausea</li>
<li>nervousness</li>
<li>nosebleed</li>
<li>pain</li>
<li>pale skin</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>slow or fast heartbeat</li>
<li>sneezing</li>
<li>sore throat</li>
<li>stomach cramps</li>
<li>stuffy or runny nose</li>
<li>tenderness</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trouble breathing with exertion</li>
<li>ulcers, sores, or white spots in the mouth</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
<li>watery or bloody diarrhea</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>burning, tingling, numbness or pain in the hands, arms, feet, or legs</li>
<li>chest pain</li>
<li>confusion</li>
<li>dark urine</li>
<li>decreased urine</li>
<li>depressed mood</li>
<li>difficulty with chewing, swallowing, or talking</li>
<li>double vision</li>
<li>drooping eyelids</li>
<li>drowsiness</li>
<li>dry skin and hair</li>
<li>facial swelling</li>
<li>feeling cold</li>
<li>general feeling of discomfort or illness</li>
<li>inability to move the arms and legs</li>
<li>irritability</li>
<li>light-colored stools</li>
<li>lightheadedness</li>
<li>muscle cramp, stiffness, or weakness</li>
<li>numbness in the hands, feet, or lips</li>
<li>rapid, shallow breathing</li>
<li>seizures</li>
<li>sensation of pins and needles</li>
<li>sensitivity to heat</li>
<li>skin rash</li>
<li>stabbing pain</li>
<li>stiff neck or back</li>
<li>sudden numbness and weakness in the arms and legs</li>
<li>sweating</li>
<li>thickening of bronchial secretions</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
<li>upper right abdominal or stomach pain</li>
<li>yellow eyes and skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>darkening of the skin</li>
<li>fainting</li>
<li>hives, itching</li>
<li>indigestion</li>
<li>joint or muscle pain</li>
<li>joint stiffness or swelling</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>increased hunger</li>
<li>increased urination</li>
<li>sweating</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of atezolizumab may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back, neck, arm, or leg pain</li>
<li>difficulty in moving</li>
<li>loss of or change in taste</li>
<li>thinning of the hair or hair loss</li>
<li>unsteadiness or awkwardness</li>
<li>weakness in the arms, hands, legs, or feet</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to atezolizumab: intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Venous thromboembolism<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (15%), pruritus (13%)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Immune-related thyroid disorders (e.g., hyperthyroidism, hypothyroidism)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (25%), constipation (21%), diarrhea (18%), abdominal pain (17%), vomiting (17%)</p>
<p><b>Common</b> (1% to 10%): Dehydration, intestinal obstruction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions (greater than 20%) were fatigue, decreased appetite, nausea, urinary tract infection, pyrexia, and constipation.  The most common Grade 3 to 4 adverse reactions (greater than 2%) were urinary tract infection, anemia, fatigue, dehydration, intestinal obstruction, urinary obstruction, hematuria, dyspnea, acute kidney injury, abdominal pain, venous thromboembolism, sepsis, and pneumonia.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (22%)</p>
<p><b>Common</b> (1% to 10%): Urinary obstruction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, lymphopenia, increased alkaline phosphatase, increased alkaline phosphatase<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Acute kidney injury, liver enzyme increase, increased ALT, increased AST</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Immune related colitis (19.7%)</p>
<p><b>Common</b> (1% to 10%): Immune related pneumonitis, immune related hepatitis, sepsis</p>
<p><b>Frequency not reported</b>: Immune related endocrinopathies<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Infusion related reactions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (26%)</p>
<p><b>Common</b> (1% to 10%): Hyponatremia, hyperglycemia, hypoalbuminemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back/neck pain (15%), arthralgia (14%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Meningoencephalitis, myasthenic syndrome/myasthenia gravis, Guillain-Barre<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Ocular inflammatory toxicity<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (52%), pyrexia (21%), peripheral edema (18%)</p>
<p><b>Common</b> (1% to 10%): Increased creatinine<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusional state<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (16%), cough (14%)</p>
<p><b>Common</b> (1% to 10%): Dyspnea, pneumonia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Tecentriq (atezolizumab)." Genentech, South San Francisco, CA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What is the cost of Tecentriq?</li>
<li>How effective is it?</li>
<li>Is this a chemotherapy or immunotherapy drug?</li>
<li>Does it cause hair loss?</li>
<li>How is it administered?</li>
<li>What type of cancer is Tecentriq used to treat?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Tecentriq (atezolizumab)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: anti-PD-1 monoclonal antibodies</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tecentriq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Hepatocellular Carcinoma</li>
<li>Melanoma</li>
<li>Bladder Cancer</li>
<li>Breast Cancer</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to atezolizumab: intravenous solution</i></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Venous thromboembolism<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (15%), pruritus (13%)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Immune-related thyroid disorders (e.g., hyperthyroidism, hypothyroidism)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (25%), constipation (21%), diarrhea (18%), abdominal pain (17%), vomiting (17%)</p><p><b>Common</b> (1% to 10%): Dehydration, intestinal obstruction<sup>[Ref]</sup></p><h3>General</h3><p>The most common adverse reactions (greater than 20%) were fatigue, decreased appetite, nausea, urinary tract infection, pyrexia, and constipation.  The most common Grade 3 to 4 adverse reactions (greater than 2%) were urinary tract infection, anemia, fatigue, dehydration, intestinal obstruction, urinary obstruction, hematuria, dyspnea, acute kidney injury, abdominal pain, venous thromboembolism, sepsis, and pneumonia.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (22%)</p><p><b>Common</b> (1% to 10%): Urinary obstruction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia, lymphopenia, increased alkaline phosphatase, increased alkaline phosphatase<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Acute kidney injury, liver enzyme increase, increased ALT, increased AST</p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Immune related colitis (19.7%)</p><p><b>Common</b> (1% to 10%): Immune related pneumonitis, immune related hepatitis, sepsis</p><p><b>Frequency not reported</b>: Immune related endocrinopathies<sup>[Ref]</sup></p><h3>Local</h3><p><b>Frequency not reported</b>: Infusion related reactions<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (26%)</p><p><b>Common</b> (1% to 10%): Hyponatremia, hyperglycemia, hypoalbuminemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back/neck pain (15%), arthralgia (14%)<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Frequency not reported</b>: Meningoencephalitis, myasthenic syndrome/myasthenia gravis, Guillain-Barre<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Ocular inflammatory toxicity<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (52%), pyrexia (21%), peripheral edema (18%)</p><p><b>Common</b> (1% to 10%): Increased creatinine<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Confusional state<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Hematuria<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (16%), cough (14%)</p><p><b>Common</b> (1% to 10%): Dyspnea, pneumonia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Tecentriq (atezolizumab)." Genentech, South San Francisco, CA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What is the cost of Tecentriq?</li>
<li>How effective is it?</li>
<li>Is this a chemotherapy or immunotherapy drug?</li>
<li>Does it cause hair loss?</li>
<li>How is it administered?</li>
<li>What type of cancer is Tecentriq used to treat?</li>
</ul><h2>More about Tecentriq (atezolizumab)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: anti-PD-1 monoclonal antibodies</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Tecentriq &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hepatocellular Carcinoma</li>
<li>Melanoma</li>
<li>Bladder Cancer</li>
<li>Breast Cancer</li>
<li data-more-config-id="list-data-resources-conditions">... +3 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>